Nakashima A, Nakagawa K, Ohgi S, Horikawa T, Kamura T, Saito H. Case reportTransient thyrotoxicosis following prolonged use of gonadotropin-releasing hormone agonist in women with endometriosis – a case report. Archives of Medical Science. 2008;4(2):200-203.
APA
Nakashima, A., Nakagawa, K., Ohgi, S., Horikawa, T., Kamura, T., & Saito, H. (2008). Case reportTransient thyrotoxicosis following prolonged use of gonadotropin-releasing hormone agonist in women with endometriosis – a case report. Archives of Medical Science, 4(2), 200-203.
Chicago
Nakashima, Akira, Koji Nakagawa, Shirei Ohgi, Takashi Horikawa, Toshiharu Kamura, and Hidekazu Saito. 2008. "Case reportTransient thyrotoxicosis following prolonged use of gonadotropin-releasing hormone agonist in women with endometriosis – a case report". Archives of Medical Science 4 (2): 200-203.
Harvard
Nakashima, A., Nakagawa, K., Ohgi, S., Horikawa, T., Kamura, T., and Saito, H. (2008). Case reportTransient thyrotoxicosis following prolonged use of gonadotropin-releasing hormone agonist in women with endometriosis – a case report. Archives of Medical Science, 4(2), pp.200-203.
MLA
Nakashima, Akira et al. "Case reportTransient thyrotoxicosis following prolonged use of gonadotropin-releasing hormone agonist in women with endometriosis – a case report." Archives of Medical Science, vol. 4, no. 2, 2008, pp. 200-203.
Vancouver
Nakashima A, Nakagawa K, Ohgi S, Horikawa T, Kamura T, Saito H. Case reportTransient thyrotoxicosis following prolonged use of gonadotropin-releasing hormone agonist in women with endometriosis – a case report. Archives of Medical Science. 2008;4(2):200-203.
This paper reports two cases showing transient thyrotoxicosis caused by prolonged use of gonadotropin-releasing hormone (GnRH) agonist. Case 1, a 31-year-old woman, was administered GnRH-agonist (leuprorelin acetate) for treatment of endometriosis. After four months she showed thyroid dysfunction. Case 2, a 43-year-old woman, who was previously diagnosed with chronic thyroiditis, was treated with GnRH-agonist (nafarelin acetate) for her endometriosis. Five months later, her thyroid functions worsened. After discontinuation of the GnRH-agonist, thyroid function of both cases recovered. In selected patients, who are on GnRH-agonist, attention to thyroid function is important.